If you’re interested in being genetically tested for dilated cardiomyopathy (DCM), you can do so by simply clicking the links below to learn about Invitae’s DCM genetic testing options. For screening recommendations, please click here.
The DCM Foundation is very pleased to partner with Invitae on the Patient Insights Network (PIN) Program. DCM patients and their at-risk family members can register for the PIN to get information about DCM clinical trials and studies that help researchers and drug developers find better treatments, faster. Invitae offers sponsored, no-charge genetic testing and counseling for individuals suspected of having a familial cardiomyopathy or arrhythmia. Click the link below and scroll to the bottom of the webpage for more information on Invitae’s genetic testing options.
Learn More about No-Charge Genetic Testing
To order your Invitae genetic test now for a fee, please click here.
Bristol Myers Squibb is currently recruiting participants for a clinical study in MYH7-related DCM patients.
The DCM Research Project, housed at the Ohio State University with consortium sites across the United States, aims to advance understanding of the genetics of DCM by conducting family-based research studies that include a large number of families.
The University of Miami is currently recruiting participants for a clinical study to evaluate the safety and effectiveness of stem cells for those living with DCM. Click here to learn more about this study.
Additional research opportunities may be found at clinicaltrials.gov. If you know of other studies that the DCM Foundation may want to support, please contact us.
*Part of the DCM Foundation’s mission is to share information about the latest clinical trials and research opportunities in the DCM field. The DCM Foundation does not imply or warrant the effectiveness or outcome of these or any clinical research trial. The DCM Foundation has not evaluated the shared information in any way. Participation in clinical trials is at the sole discretion of the potential participant. Potential participants should always know the risks and potential benefits of clinical trials and should talk to their healthcare provider before participating.